Glaxo | search
Click here to view Glaxo news from 60+ newspapers.
Bookmark or Share- Home | GSK USPress releases. April 24 2024 US FDA accepts for priority review GSK’s application for an expanded indication of Jemperli (dostarlimab-gxly) plus chemotherapy to include all adult patients with primary advanced or recurrent endometrial cancer. April 17 2024 New long-term data show SHINGRIX continues to provide high protection against shingles ...
- Home | GSKOur purpose. We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.
- Company | GSK USAt a glance. GSK has a significant footprint in the US across commercial, R&D, manufacturing, and corporate functions. We employ ~15,000 people across the US and have two corporate hubs. Explore GSK in the US.
- GSK plc - WikipediaBy 1999, Glaxo Wellcome had become the world's third-largest pharmaceutical company by revenues (behind Novartis and Merck), with a global market share of around 4 per cent. Its products included Imigran (for the treatment of migraine), salbutamol (Ventolin) (for the treatment of asthma), Zovirax (for the treatment of coldsores), and Retrovir ...
- Company | GSKA preventative patient-centred approach is key to transforming respiratory care and relieving struggling services. ‘It can get very serious, very quickly’: the symptoms, risks, and ways to prevent pneumonia everyone should know about. 'Prevention is the best medicine to stop disease before it starts'. Millions of people living with chronic ...
More
